By studying the human disease leprosy as a model, we determined that S100A12 was more highly expressed in skin lesions from leprosy patients with the self-limited T-lep vs. the progressive L-lep form, indicating that expression of S100A12 at the site of infection correlates with the ability to contain the infection. This evidence concerns the gene S100A12 and leprosy.